Management of Olecranon Bursitis
Conservative management is the first-line treatment for olecranon bursitis, including rest, ice, NSAIDs, and aspiration in select cases, as surgical intervention should be reserved for refractory cases due to higher complication rates. 1
Diagnosis and Assessment
Clinical Presentation:
- Swelling over the posterior elbow (olecranon process)
- May present with erythema, warmth, tenderness
- Possible history of trauma, repetitive pressure, or infection
- Pain may be exacerbated with elbow movement or direct pressure
Differentiation between Septic vs. Non-septic Bursitis:
- Aspiration of bursal fluid is essential for diagnosis when infection is suspected 2
- Send fluid for cell count, Gram stain, culture
- Septic bursitis typically presents with more acute onset, systemic symptoms, and marked erythema
Treatment Algorithm
1. Non-septic Olecranon Bursitis (Primary Approach)
First-line Treatment:
- Rest and protection of the affected elbow
- Ice application for 15-20 minutes several times daily
- NSAIDs for pain and inflammation
- Naproxen 500mg twice daily is recommended for acute bursitis 3
- Continue until symptoms resolve, typically 7-14 days
- Avoid direct pressure on the olecranon
Second-line Treatment (if no improvement after 2 weeks):
- Aspiration of bursal fluid
- Aseptic technique is crucial
- Aspiration alone does not increase risk of infection in aseptic bursitis 1
- Compression wrap after aspiration
- Continue NSAIDs and activity modification
- Aspiration of bursal fluid
Refractory Cases:
- Consider surgical referral if no improvement after 4-6 weeks of conservative management
- Arthroscopic or open bursectomy may be necessary for chronic cases 4
2. Septic Olecranon Bursitis
Immediate Management:
- Aspiration of bursal fluid for diagnosis
- Empiric antibiotic therapy pending culture results
- Possible hospital admission for severe cases or immunocompromised patients 5
Ongoing Treatment:
- Repeat aspirations as needed
- Complete antibiotic course (typically 10-14 days)
- Surgical drainage may be required for refractory cases
Important Considerations
Corticosteroid Injections
Caution with corticosteroid injections: Despite rapid symptom relief, intrabursal corticosteroid injections are associated with significantly higher complication rates including:
While triamcinolone acetonide is FDA-approved for bursitis 8, evidence shows that corticosteroid injections should be reserved for refractory cases due to complications.
Surgical vs. Non-surgical Management
- Research demonstrates that non-surgical management is significantly more effective and safer than surgical management for olecranon bursitis 1
- Surgery is associated with:
- Lower rates of clinical resolution
- Higher rates of overall complications
- Increased risk of persistent drainage
- Greater likelihood of bursal infection
Follow-up and Monitoring
- Regular assessment of treatment response every 2-3 weeks
- Monitor for signs of infection or recurrence
- For chronic cases, measurement of arm circumference at fixed distances above and below the olecranon can help quantify swelling 5
Prevention Strategies
- Avoid direct pressure on the elbow
- Use elbow pads during activities that put pressure on the olecranon
- Proper ergonomic setup for work environments
- Early intervention at first signs of swelling or discomfort
Conclusion
The evidence strongly supports conservative management as the first-line approach for olecranon bursitis. Surgical intervention should be reserved for cases that fail to respond to conservative measures after 4-6 weeks. Corticosteroid injections, while effective for symptom relief, carry significant risks and should be used cautiously in select cases.